查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1620815

大鼠和小鼠模型市場：按模型類型、技術、服務、治療領域和最終用戶分類 - 2025-2030 年全球預測

Rat & Mouse Model Market by Model Type, Technology, Service, Therapeutic Area, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年大鼠和小鼠模型市場的市場規模為22.7億美元，預計2024年將達到24.5億美元，複合年成長率為8.26%，預計到2030年將達到39.7億美元。

大鼠和小鼠模型市場在生物醫學研究中發揮重要作用，由於這些囓齒動物與人類之間的遺傳和生物學相似性，為人類疾病機制提供了寶貴的見解。這些模型對於研究疾病進展、藥物交互作用和基因表現至關重要，對於製藥和生物技術產業的臨床前測試也至關重要。應用範圍涵蓋腫瘤學、心臟病學、神經科學、免疫學和遺傳學研究，最終用戶包括研究機構、製藥公司和受託研究機構。目前，市場成長的推動因素包括基因工程技術的進步、研發投資的增加以及需要創新治療方法的慢性疾病數量的增加。個人化醫療存在發展機會，客製化小鼠模型可以加速標靶治療的發展。此外，CRISPR-Cas9技術的興起和基因轉殖人源化小鼠模型的廣泛使用將擴大研究能力並提供利潤豐厚的成長途徑。然而，市場擴張受到動物測試、監管挑戰以及替代體外和電腦模型轉變等倫理問題的限制。維持活體動物群體的複雜性和成本也是一個主要限制。為了利用這些機會，相關人員應專注於人工智慧和機器學習的結合，以提高動物研究資料分析的有效性。強大的試管內模擬技術的發展可以補充並有可能取代傳統的動物模型，確保與不斷變化的監管和道德標準保持一致。創新也應著重於改進基因操作程序，以提高模型的準確性和相關性。雖然大鼠和小鼠模型市場目前受益於穩定的需求前景，但由於技術進步和不斷變化的道德觀點，它面臨著充滿活力的未來，需要該領域的參與者採取適應性策略。隨著不斷的創新和策略調整，這個市場具有巨大的成長潛力。

主要市場統計
基準年[2023] 22.7億美元
預計年份 [2024] 24.5億美元
預測年份 [2030] 39.7億美元
複合年成長率（%） 8.26%

市場動態：快速發展的大鼠和小鼠模型市場的關鍵市場洞察

供需的動態交互作用正在改變老鼠模型市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 對基因工程模型檢驗治療標靶的龐大需求
    • 醫藥和生技領域研發費用增加
    • 個人化醫療需求快速成長
  • 市場限制因素
    • 大鼠和小鼠模型的倫理問題和局限性
  • 市場機會
    • 傾向於人源化大鼠/小鼠模型
    • 不斷發展的治療研究領域
  • 市場挑戰
    • 存在替代測試方法

波特的五力：駕馭大鼠和小鼠模型市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解大鼠和小鼠模型市場的外部影響

外部宏觀環境因素在塑造大鼠和小鼠模型市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解大鼠/小鼠模型市場的競爭狀況

對大鼠和小鼠模型市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣大鼠模型市場供應商績效評估

FPNV定位矩陣是評估大鼠和小鼠模型市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議，以繪製大鼠和小鼠模型市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對大鼠和小鼠模型市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開發：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、未開發地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 對基因工程模型檢驗治療標靶的龐大需求
      • 增加製藥和生技領域研發活動的支出
      • 個人化醫療需求快速成長
    • 抑制因素
      • 大鼠和小鼠模型的倫理問題和局限性
    • 機會
      • 致力於具有人性化的主題
      • 不斷發展的治療研究領域
    • 任務
      • 替代測試方法的存在
  • 市場區隔分析
    • 模型類型：基因轉殖大鼠提供遺傳功能和遺傳疾病發展的重要見解
    • 服務：由於需要產生特定的遺傳背景，擴大了大鼠和小鼠模型在育種服務中的使用
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章依模型類型分類的大鼠和小鼠模型市場

  • 透過調節或手術改造的大鼠
  • 基因改造老鼠
  • 雜交或同類大鼠
  • 免疫力缺乏大鼠
  • 近交系大鼠
  • 近交系大鼠

第7章大鼠和小鼠模型市場：依技術分類

  • 更脆
  • 胚胎幹細胞注射
  • 顯微注射
  • 核轉移

第8章大鼠模型市場：依服務分類

  • 選育
  • 冷凍保存
  • 基因檢測
  • 引入授權的模型
  • 隔離
  • 衍生

第 9 章按治療領域分類的大鼠和小鼠模型市場

  • 心血管疾病
  • 糖尿病
  • 免疫學和炎症
  • 神經病學
  • 腫瘤學
  • 毒理學

第 10 章 大鼠和小鼠模型市場：依最終使用者分類

  • 學術研究所
  • 合約調查機構
  • 製藥和生物技術公司

第11章 北美和南美大鼠模型市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章亞太地區大鼠模型市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章歐洲、中東和非洲大鼠模型市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Charles River 實驗室利用先進的基因工程小鼠模型為臨床前研究提供支持
    • 創新的小鼠模式為慢性淋巴性白血病和里氏轉化的新治療方法鋪平了道路
    • 發展小鼠模型來闡明 IL-6 在虛弱和老化中的作用
  • 戰略分析和建議

公司名單

  • Allentown, Inc.
  • Aragen Life Sciences
  • Biocytogen
  • Biomere Biomedical Research Models, Inc.
  • Champions Oncology, Inc.
  • Charles River Laboratories International, Inc.
  • Crown Bioscience, Inc. by JSR Corp.
  • Cyagen US Inc.
  • Envigo by Inotiv, Inc.
  • GemPharmatech
  • GenOway SA
  • Harbour Biomed
  • Hera BioLabs
  • Ingenious Targeting Laboratory
  • Janvier Labs
  • Oncodesign Precision Medicine
  • Ozgene Pty Ltd.
  • PerkinElmer, Inc.
  • Pharmatest Services Oy
  • PolyGene AG
  • Taconic Biosciences, Inc.
  • The Jackson Laboratory
  • TransCure Bioservices
  • TransViragen, Inc.
  • Vivo Bio Tech Ltd.
Product Code: MRR-3A2E844FF329

The Rat & Mouse Model Market was valued at USD 2.27 billion in 2023, expected to reach USD 2.45 billion in 2024, and is projected to grow at a CAGR of 8.26%, to USD 3.97 billion by 2030.

The rat and mouse model market serves a crucial role in biomedical research, offering a valuable insight into human disease mechanisms due to genetic and biological similarities between these rodents and humans. These models are essential for studying disease progression, drug interactions, and genetic expressions, thus a necessity in preclinical trials for pharmaceuticals and biotechnology industries. The application scope spans across oncology, cardiology, neuroscience, immunology, and genetic research, with end-users including research institutions, pharmaceutical companies, and contract research organizations. Currently, market growth is propelled by advancements in genetic engineering technologies, rising R&D investments, and an increasing prevalence of chronic diseases necessitating innovative therapeutics. Opportunities lie in personalized medicine, where customized mouse models can accelerate the development of targeted therapies. Additionally, the rise of CRISPR-Cas9 technology and expanded use of humanized mouse models through genetic modification broaden research capabilities, offering lucrative growth avenues. However, market expansion is constrained by ethical concerns regarding animal testing, regulatory challenges, and the transition towards alternative in vitro and in silico models. The complexity and cost associated with maintaining live animal colonies are also significant limitations. To capitalize on these opportunities, stakeholders should focus on integrating AI and machine learning to enhance data analysis efficacy from animal studies. Developing robust in vitro simulation techniques can complement and potentially replace traditional animal models, ensuring alignment with changing regulatory and ethical standards. Innovation should also focus on refining genetic manipulation procedures to improve model accuracy and relevance. While currently benefitting from a robust demand outlook, the rat and mouse model market faces a dynamic future, driven by technological advancements and shifting ethical perspectives, demanding adaptive strategies from players in the sector. Through continuous innovation and strategic adaptation, the market promises significant growth potential.

KEY MARKET STATISTICS
Base Year [2023] USD 2.27 billion
Estimated Year [2024] USD 2.45 billion
Forecast Year [2030] USD 3.97 billion
CAGR (%) 8.26%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Rat & Mouse Model Market

The Rat & Mouse Model Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Significant demand for genetically modified models to validate therapeutic targets
    • Rising expenditures in R&D activities in the pharmaceutical and biotechnology sector
    • Surge in demand for personalized medicine
  • Market Restraints
    • Ethical concerns and limitation of rat & mouse model
  • Market Opportunities
    • Inclination towards humanized rat & mouse model
    • Growing therapeutic research areas
  • Market Challenges
    • Presence of alternative testing methods

Porter's Five Forces: A Strategic Tool for Navigating the Rat & Mouse Model Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Rat & Mouse Model Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Rat & Mouse Model Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Rat & Mouse Model Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Rat & Mouse Model Market

A detailed market share analysis in the Rat & Mouse Model Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Rat & Mouse Model Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Rat & Mouse Model Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Rat & Mouse Model Market

A strategic analysis of the Rat & Mouse Model Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Rat & Mouse Model Market, highlighting leading vendors and their innovative profiles. These include Allentown, Inc., Aragen Life Sciences, Biocytogen, Biomere Biomedical Research Models, Inc., Champions Oncology, Inc., Charles River Laboratories International, Inc., Crown Bioscience, Inc. by JSR Corp., Cyagen US Inc., Envigo by Inotiv, Inc., GemPharmatech, GenOway S.A., Harbour Biomed, Hera BioLabs, Ingenious Targeting Laboratory, Janvier Labs, Oncodesign Precision Medicine, Ozgene Pty Ltd., PerkinElmer, Inc., Pharmatest Services Oy, PolyGene AG, Taconic Biosciences, Inc., The Jackson Laboratory, TransCure Bioservices, TransViragen, Inc., and Vivo Bio Tech Ltd..

Market Segmentation & Coverage

This research report categorizes the Rat & Mouse Model Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Model Type, market is studied across Conditioned or Surgically Modified Rats, Genetically Modified Rats, Hybrid or Congenic Rats, Immunodeficient Rats, Inbred Rats, and Outbred Rats.
  • Based on Technology, market is studied across CRISPR, Embryonic Stem Cell Injection, Microinjection, and Nuclear Transfer.
  • Based on Service, market is studied across Breeding, Cryopreservation, Genetic Testing, Model-in-Licensing, Quarantine, and Rederivation.
  • Based on Therapeutic Area, market is studied across Cardiovascular Disease, Diabetes, Immunology & Inflammation, Neurology, Oncology, and Toxicology.
  • Based on End-User, market is studied across Academic & Research Institutes, Contract Research Organizations, and Pharmaceutical & Biotechnology Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Significant demand for genetically modified models to validate therapeutic targets
      • 5.1.1.2. Rising expenditures in R&D activities in the pharmaceutical and biotechnology sector
      • 5.1.1.3. Surge in demand for personalized medicine
    • 5.1.2. Restraints
      • 5.1.2.1. Ethical concerns and limitation of rat & mouse model
    • 5.1.3. Opportunities
      • 5.1.3.1. Inclination towards humanized rat & mouse model
      • 5.1.3.2. Growing therapeutic research areas
    • 5.1.4. Challenges
      • 5.1.4.1. Presence of alternative testing methods
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Model Type: Significant critical insights provided by genetically modified rats into genetic functions and pathogenesis of genetic diseases
    • 5.2.2. Service: Expanding usage of rat and mouse models for breeding services due to the necessity to produce specific genetic backgrounds
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Rat & Mouse Model Market, by Model Type

  • 6.1. Introduction
  • 6.2. Conditioned or Surgically Modified Rats
  • 6.3. Genetically Modified Rats
  • 6.4. Hybrid or Congenic Rats
  • 6.5. Immunodeficient Rats
  • 6.6. Inbred Rats
  • 6.7. Outbred Rats

7. Rat & Mouse Model Market, by Technology

  • 7.1. Introduction
  • 7.2. CRISPR
  • 7.3. Embryonic Stem Cell Injection
  • 7.4. Microinjection
  • 7.5. Nuclear Transfer

8. Rat & Mouse Model Market, by Service

  • 8.1. Introduction
  • 8.2. Breeding
  • 8.3. Cryopreservation
  • 8.4. Genetic Testing
  • 8.5. Model-in-Licensing
  • 8.6. Quarantine
  • 8.7. Rederivation

9. Rat & Mouse Model Market, by Therapeutic Area

  • 9.1. Introduction
  • 9.2. Cardiovascular Disease
  • 9.3. Diabetes
  • 9.4. Immunology & Inflammation
  • 9.5. Neurology
  • 9.6. Oncology
  • 9.7. Toxicology

10. Rat & Mouse Model Market, by End-User

  • 10.1. Introduction
  • 10.2. Academic & Research Institutes
  • 10.3. Contract Research Organizations
  • 10.4. Pharmaceutical & Biotechnology Companies

11. Americas Rat & Mouse Model Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Rat & Mouse Model Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Rat & Mouse Model Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Enhancing Preclinical Research through Advanced Genetically Modified Mouse Models by Charles River Laboratories
    • 14.3.2. Innovative Mouse Model Paves Way for New Therapies in Chronic Lymphocytic Leukaemia and Richter Transformation
    • 14.3.3. Pioneering a Mouse Model to Elucidate the Role of IL-6 in Frailty and Aging
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Allentown, Inc.
  • 2. Aragen Life Sciences
  • 3. Biocytogen
  • 4. Biomere Biomedical Research Models, Inc.
  • 5. Champions Oncology, Inc.
  • 6. Charles River Laboratories International, Inc.
  • 7. Crown Bioscience, Inc. by JSR Corp.
  • 8. Cyagen US Inc.
  • 9. Envigo by Inotiv, Inc.
  • 10. GemPharmatech
  • 11. GenOway S.A.
  • 12. Harbour Biomed
  • 13. Hera BioLabs
  • 14. Ingenious Targeting Laboratory
  • 15. Janvier Labs
  • 16. Oncodesign Precision Medicine
  • 17. Ozgene Pty Ltd.
  • 18. PerkinElmer, Inc.
  • 19. Pharmatest Services Oy
  • 20. PolyGene AG
  • 21. Taconic Biosciences, Inc.
  • 22. The Jackson Laboratory
  • 23. TransCure Bioservices
  • 24. TransViragen, Inc.
  • 25. Vivo Bio Tech Ltd.

LIST OF FIGURES

  • FIGURE 1. RAT & MOUSE MODEL MARKET RESEARCH PROCESS
  • FIGURE 2. RAT & MOUSE MODEL MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL RAT & MOUSE MODEL MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS RAT & MOUSE MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS RAT & MOUSE MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES RAT & MOUSE MODEL MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES RAT & MOUSE MODEL MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC RAT & MOUSE MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC RAT & MOUSE MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA RAT & MOUSE MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA RAT & MOUSE MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. RAT & MOUSE MODEL MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. RAT & MOUSE MODEL MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. RAT & MOUSE MODEL MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL RAT & MOUSE MODEL MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. RAT & MOUSE MODEL MARKET DYNAMICS
  • TABLE 7. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY CONDITIONED OR SURGICALLY MODIFIED RATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY GENETICALLY MODIFIED RATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY HYBRID OR CONGENIC RATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY IMMUNODEFICIENT RATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY INBRED RATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY OUTBRED RATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY CRISPR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY EMBRYONIC STEM CELL INJECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY MICROINJECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY NUCLEAR TRANSFER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY BREEDING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY CRYOPRESERVATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY GENETIC TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY MODEL-IN-LICENSING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY QUARANTINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY REDERIVATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY IMMUNOLOGY & INFLAMMATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY TOXICOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL RAT & MOUSE MODEL MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS RAT & MOUSE MODEL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 60. MEXICO RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 61. MEXICO RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 62. MEXICO RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 67. UNITED STATES RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES RAT & MOUSE MODEL MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC RAT & MOUSE MODEL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 75. AUSTRALIA RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. AUSTRALIA RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 78. AUSTRALIA RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. CHINA RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. CHINA RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 82. CHINA RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 83. CHINA RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 84. CHINA RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. INDIA RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. INDIA RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 87. INDIA RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 88. INDIA RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 89. INDIA RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. INDONESIA RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. INDONESIA RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 92. INDONESIA RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 93. INDONESIA RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 94. INDONESIA RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. JAPAN RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. JAPAN RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 97. JAPAN RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 98. JAPAN RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 99. JAPAN RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. MALAYSIA RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. MALAYSIA RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 102. MALAYSIA RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 103. MALAYSIA RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 104. MALAYSIA RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. PHILIPPINES RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. PHILIPPINES RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 107. PHILIPPINES RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 108. PHILIPPINES RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 109. PHILIPPINES RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. SINGAPORE RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. SINGAPORE RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 112. SINGAPORE RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 113. SINGAPORE RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 114. SINGAPORE RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. SOUTH KOREA RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. SOUTH KOREA RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 117. SOUTH KOREA RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 118. SOUTH KOREA RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 119. SOUTH KOREA RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. TAIWAN RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. TAIWAN RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 122. TAIWAN RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 123. TAIWAN RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 124. TAIWAN RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. THAILAND RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. THAILAND RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 127. THAILAND RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 128. THAILAND RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 129. THAILAND RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. VIETNAM RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. VIETNAM RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 132. VIETNAM RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 133. VIETNAM RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 134. VIETNAM RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA RAT & MOUSE MODEL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 141. DENMARK RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. DENMARK RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 143. DENMARK RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 144. DENMARK RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 145. DENMARK RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. EGYPT RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. EGYPT RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 148. EGYPT RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 149. EGYPT RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 150. EGYPT RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 151. FINLAND RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. FINLAND RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 153. FINLAND RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 154. FINLAND RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 155. FINLAND RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 156. FRANCE RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. FRANCE RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 158. FRANCE RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 159. FRANCE RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 160. FRANCE RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 161. GERMANY RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. GERMANY RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 163. GERMANY RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 164. GERMANY RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 165. GERMANY RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 166. ISRAEL RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. ISRAEL RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 168. ISRAEL RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 169. ISRAEL RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 170. ISRAEL RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 171. ITALY RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. ITALY RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 173. ITALY RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 174. ITALY RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 175. ITALY RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 176. NETHERLANDS RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. NETHERLANDS RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 178. NETHERLANDS RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 179. NETHERLANDS RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 180. NETHERLANDS RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 181. NIGERIA RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. NIGERIA RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 183. NIGERIA RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 184. NIGERIA RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 185. NIGERIA RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 186. NORWAY RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. NORWAY RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 188. NORWAY RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 189. NORWAY RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 190. NORWAY RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 191. POLAND RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. POLAND RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 193. POLAND RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 194. POLAND RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 195. POLAND RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 196. QATAR RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
  • TABLE 197. QATAR RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 198. QATAR RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 199. QATAR RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 200. QATAR RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 201. RUSSIA RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
  • TABLE 202. RUSSIA RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 203. RUSSIA RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 204. RUSSIA RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 205. RUSSIA RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 206. SAUDI ARABIA RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
  • TABLE 207. SAUDI ARABIA RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 208. SAUDI ARABIA RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 209. SAUDI ARABIA RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 210. SAUDI ARABIA RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 211. SOUTH AFRICA RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
  • TABLE 212. SOUTH AFRICA RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 213. SOUTH AFRICA RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 214. SOUTH AFRICA RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 215. SOUTH AFRICA RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 216. SPAIN RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
  • TABLE 217. SPAIN RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 218. SPAIN RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 219. SPAIN RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 220. SPAIN RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 221. SWEDEN RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
  • TABLE 222. SWEDEN RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 223. SWEDEN RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 224. SWEDEN RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 225. SWEDEN RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 226. SWITZERLAND RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
  • TABLE 227. SWITZERLAND RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 228. SWITZERLAND RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 229. SWITZERLAND RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 230. SWITZERLAND RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 231. TURKEY RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
  • TABLE 232. TURKEY RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 233. TURKEY RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 234. TURKEY RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 235. TURKEY RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED ARAB EMIRATES RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED ARAB EMIRATES RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 238. UNITED ARAB EMIRATES RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 239. UNITED ARAB EMIRATES RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 240. UNITED ARAB EMIRATES RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 241. UNITED KINGDOM RAT & MOUSE MODEL MARKET SIZE, BY MODEL TYPE, 2018-2030 (USD MILLION)
  • TABLE 242. UNITED KINGDOM RAT & MOUSE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 243. UNITED KINGDOM RAT & MOUSE MODEL MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 244. UNITED KINGDOM RAT & MOUSE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 245. UNITED KINGDOM RAT & MOUSE MODEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 246. RAT & MOUSE MODEL MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 247. RAT & MOUSE MODEL MARKET, FPNV POSITIONING MATRIX, 2023